Biomedical (basic)
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261200900066C
- Awardee
-
Integral Molecular Inc. UEI DY9KSWE8EJB8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $150,000
Award facts
- Opportunity
-
- N43CO9702311 Solicitation number
- Contract value 100% obligated
- $150,000.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $150,000 |
About this award
This contract award is to Integral Molecular Inc., a biotechnology company specializing in membrane protein research and antibody development. The contract, valued at $150,000.00, was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), under the Small Business Innovation Research (SBIR) program. The contract is for a Phase I research project focused on biomedical research. It is designated as a total small business set-aside.
Integral Molecular has received numerous prime contracts and subcontracts from various federal agencies, including NIH, Centers for Disease Control and Prevention (CDC), and the Department of the Army, to provide a range of biomedical research services and products. These include membrane proteome array services, monoclonal antibody development, adjuvant target discovery for vaccines, and immunologic analysis supporting infectious disease research programs.
Quick answers
Who was awarded contract HHSN261200900066C?
HHSN261200900066C was awarded to Integral Molecular Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2009.
How much is contract HHSN261200900066C worth?
The government has obligated $150,000 on HHSN261200900066C.
Was contract HHSN261200900066C competed?
The extent of competition for HHSN261200900066C was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award